4.8 Article

Smoothened stimulation by membrane sterols drives Hedgehog pathway activity

期刊

NATURE
卷 571, 期 7764, 页码 284-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41586-019-1355-4

关键词

-

资金

  1. National Institutes of Health (NIH) [DP5OD023048, R01GM127359, R01GM102498]
  2. Swiss National Science Foundation
  3. Pew Charitable Trusts
  4. American Cancer Society
  5. National Science Foundation Graduate Research Fellowships
  6. Gerhard Casper Stanford Graduate Fellowship
  7. National Cancer Institute [ACB-12002]
  8. National Institute of General Medical Sciences [AGM-12006]
  9. DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]
  10. NIH-Office of Research Infrastructure Programs, High-End Instrumentation Grant [1S100D012289-01A1]

向作者/读者索取更多资源

Hedgehog signalling is fundamental to embryonic development and postnatal tissue regeneration(1). Aberrant postnatal Hedgehog signalling leads to several malignancies, including basal cell carcinoma and paediatric medulloblastoma(2). Hedgehog proteins bind to and inhibit the transmembrane cholesterol transporter Patched-1 (PTCH1), which permits activation of the seven-transmembrane transducer Smoothened (SMO) via a mechanism that is poorly understood. Here we report the crystal structure of active mouse SMO bound to both the agonist SAG21k and to an intracellular binding nanobody that stabilizes a physiologically relevant active state. Analogous to other G protein-coupled receptors, the activation of SMO is associated with subtle motions in the extracellular domain, and larger intracellular changes. In contrast to recent models(3-5), a cholesterol molecule that is critical for SMO activation is bound deep within the seven-transmembrane pocket. We propose that the inactivation of PTCH1 by Hedgehog allows a transmembrane sterol to access this seven-transmembrane site (potentially through a hydrophobic tunnel), which drives the activation of SMO. These results-combined with signalling studies and molecular dynamics simulations-delineate the structural basis for PTCH1-SMO regulation, and suggest a strategy for overcoming clinical resistance to SMO inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据